Daewon Pharmaceutical Co. Ltd. (003220) — Cash Flow Reinvestment Rate
Daewon Pharmaceutical Co. Ltd. (003220) has a Cash Flow Reinvestment Rate of 1.25x as of March 2026, reinvesting ₩11.52 Billion (capex ₩11.26 Billion plus investments ₩-261.35 Million) from operating cash flow of ₩9.21 Billion. Explore capital reinvestment ratio of Daewon Pharmaceutical Co. Ltd. to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Daewon Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Daewon Pharmaceutical Co. Ltd. across 15 annual periods. See Daewon Pharmaceutical Co. Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Annual Cash Flow Reinvestment Rate for Daewon Pharmaceutical Co. Ltd. (2011–2025)
Year-by-year capital reinvestment analysis for Daewon Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see how efficiently does Daewon Pharmaceutical Co. Ltd. generate cash.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.14x | ₩48.21 Billion | ₩42.31 Billion | ₩42.13 Billion | ▼ -48.1% |
| 2024 | 2.20x | ₩65.99 Billion | ₩30.04 Billion | ₩53.58 Billion | ▲ +27.9% |
| 2023 | 1.72x | ₩88.88 Billion | ₩51.73 Billion | ₩20.61 Billion | ▲ +39.5% |
| 2022 | 1.23x | ₩41.05 Billion | ₩33.33 Billion | ₩13.37 Billion | ▲ +35.6% |
| 2021 | 0.91x | ₩20.36 Billion | ₩22.41 Billion | ₩4.10 Billion | ▲ +99.2% |
| 2020 | 0.46x | ₩11.38 Billion | ₩24.95 Billion | ₩11.35 Billion | ▼ -68.8% |
| 2019 | 1.46x | ₩45.24 Billion | ₩30.97 Billion | ₩33.03 Billion | ▲ +39.8% |
| 2018 | 1.04x | ₩41.81 Billion | ₩40.03 Billion | ₩40.82 Billion | ▼ -72.8% |
| 2017 | 3.84x | ₩16.39 Billion | ₩4.27 Billion | ₩14.71 Billion | ▲ +96.1% |
| 2016 | 1.96x | ₩40.74 Billion | ₩20.79 Billion | ₩20.57 Billion | ▲ +142.1% |
| 2015 | 0.81x | ₩20.89 Billion | ₩25.82 Billion | ₩19.80 Billion | ▼ -21.5% |
| 2014 | 1.03x | ₩17.98 Billion | ₩17.45 Billion | ₩15.84 Billion | ▼ -24.7% |
| 2013 | 1.37x | ₩16.85 Billion | ₩12.32 Billion | ₩9.85 Billion | ▲ +472.4% |
| 2012 | 0.24x | ₩3.30 Billion | ₩13.83 Billion | ₩3.30 Billion | ▼ -58.0% |
| 2011 | 0.57x | ₩10.19 Billion | ₩17.93 Billion | ₩10.19 Billion | — |